After TPIAT and blood-sugar sensor study
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at outcomes after a procedure called TPIAT (total pancreatectomy with islet auto-transplantation), which aims to improve insulin function and blood-sugar control. It may help doctors better understand how people do over time after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were referred for TPIAT, or you had the TPIAT procedure since 2014
- You can understand Dutch (either actively or passively)
- You agree to wear a glucose monitoring sensor (FGM or CGM) at required times
- You can wear the sensor for at least 2 weeks before yearly clinical visits
- You can wear the sensor from at least 2 weeks before TPIAT, through the first 3 months after TPIAT
- You do not have known pancreatic cancer (malignancy of the pancreas)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies pancreatic islets (cells that make insulin) from people who are having part or all of their pancreas removed. It may help researchers learn more about how the pancreas works in health and disease.
This study looks at how well a second islet transplant works in people with type 1 diabetes whose first transplant stopped producing insulin or caused dangerous low blood sugar. It aims to see if getting another transplant can help control blood sugar again.
This study looks at people who receive a pancreas transplant, with or without a same-time kidney transplant, and follows them to understand their results. It may help improve how transplant teams choose patients and manage care after surgery.
This study tests a surgery that removes the entire pancreas and then transplants your own insulin-making cells (islet cells) back into your liver. It aims to relieve chronic pancreatitis pain while reducing the risk of diabetes.
This trial removes the whole pancreas in people with certain pancreatic tumors and then transplants the patient's own insulin-making cells (islets) into the liver. The goal is to prevent or reduce diabetes after surgery.
This study looks at how well a treatment works after islet cell transplantation done for people with long-term (chronic) pancreatitis. It may help doctors better understand graft (transplant) function and how to choose the best approach and follow-up.
Hear when a new Islets of Langerhans Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.